Arnold C. Hanish - 30 Dec 2025 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/Mark Rosenblum, as Attorney-in-Fact
Issuer symbol
SLRX
Transactions as of
30 Dec 2025
Net transactions value
-$17.27
Form type
4
Filing time
02 Jan 2026, 17:13:54 UTC
Previous filing
24 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HANISH ARNOLD C Director C/O SALARIUS PHARMACEUTICALS, INC., 2450 HOLCOMBE BLVD., SUITE X, HOUSTON /s/Mark Rosenblum, as Attorney-in-Fact 02 Jan 2026 0001233253

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Sale $9.6 -15 -0.3% $0.6397 5,000 30 Dec 2025 By Arnold C. Hanish Trust
transaction SLRX Common Stock Sale $7.68 -12 -100% $0.6397 0 30 Dec 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.